We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$954M
AUM Growth
+$65.8M
Cap. Flow
-$24.3M
Cap. Flow %
-2.54%
Top 10 Hldgs %
55.57%
Holding
128
New
5
Increased
22
Reduced
13
Closed
5

Top Sells

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$11.1M
2
RTX icon
RTX Corp
RTX
+$6.89M
3
NVO
Novo Nordisk
NVO
+$4.46M
4
PG icon
Procter & Gamble
PG
+$4.39M
5
SNY icon
Sanofi
SNY
+$2.82M

Sector Composition

Rank Sector Weight
1 Financials 36.28%
2 Healthcare 20.01%
3 Industrials 12.08%
4 Technology 6.87%
5 Consumer Staples 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUD icon
26
AB InBev
BUD
$159B
$10.4M 1.09%
123,800
VOO icon
27
Vanguard S&P 500 ETF
VOO
$1.03T
$10.1M 1.06%
38,920
+6,330
+19% +$1.58M
CL icon
28
Colgate-Palmolive
CL
$73.6B
$9.74M 1.02%
142,090
MO icon
29
Altria Group
MO
$109B
$8.34M 0.87%
145,190
+96,740
+200% +$4.94M
ASHR icon
30
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$7.09M 0.74%
246,800
+62,300
+34% +$1.59M
AMGN icon
31
Amgen
AMGN
$224B
$6.48M 0.68%
34,130
VDC icon
32
Vanguard Consumer Staples ETF
VDC
$7.92B
$5.9M 0.62%
40,600
BDX icon
33
Becton Dickinson
BDX
$49.4B
$5.69M 0.6%
23,370
USB icon
34
US Bancorp
USB
$100B
$5.62M 0.59%
116,700
CSCO icon
35
Cisco
CSCO
$475B
$5.61M 0.59%
103,900
-54,100
-34% -$2.63M
GILD icon
36
Gilead Sciences
GILD
$168B
$5.5M 0.58%
84,650
AKTX
37
Akari Therapeutics
AKTX
$13.5M
$5.12M 0.54%
1,788
+288
+19% +$550K
RDS.B
38
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$5.03M 0.53%
78,660
+10,060
+15% +$636K
MDT icon
39
Medtronic
MDT
$116B
$4.62M 0.48%
50,700
CI icon
40
Cigna
CI
$72.4B
$4.62M 0.48%
28,697
GOOG icon
41
Alphabet (Google) Class C
GOOG
$4.19T
$4.58M 0.48%
78,000
DVA icon
42
DaVita
DVA
$11.4B
$4.07M 0.43%
74,880
-30,800
-29% -$1.7M
VWO icon
43
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$4.04M 0.42%
94,930
+42,730
+82% +$1.76M
BIIB icon
44
Biogen
BIIB
$30.1B
$3.37M 0.35%
14,260
CELG
45
DELISTED
Celgene Corp
CELG
$3.34M 0.35%
35,370
-10,300
-23% -$901K
SRCL
46
DELISTED
Stericycle Inc
SRCL
$3.23M 0.34%
59,400
IBB icon
47
iShares Biotechnology ETF
IBB
$9.81B
$3.18M 0.33%
28,440
+2,540
+10% +$279K
SNY icon
48
Sanofi
SNY
$104B
$3.15M 0.33%
71,190
-65,850
-48% -$2.82M
T icon
49
AT&T
T
$168B
$3.05M 0.32%
128,693
BMY icon
50
Bristol-Myers Squibb
BMY
$130B
$2.96M 0.31%
62,080

Similar funds

Hikari Power's Q1 2019 Portfolio in Review

As of Q1 2019, Hikari Power held 128 positions worth $954M, up 7.4% from $889M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Hikari Power's Q1 2019 filing shows 5 new, 22 increased, 13 reduced and 5 closed positions. Its largest new stake was Vanguard Morningstar Small-Cap ETF: 10,390 shares worth $1.59M. The largest sale was Kraft Heinz, an estimated $11.1M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, down from 39% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q1 2019 buy was Vanguard Morningstar Small-Cap ETF: 10,390 shares worth $1.59M.
  • Hikari Power added most to Altria Group in Q1 2019, an estimated $4.94M increase.
  • Hikari Power's biggest Q1 2019 reduction was Kraft Heinz, cutting an estimated $11.1M.
  • Hikari Power fully exited McDonald's in Q1 2019, selling an estimated $1.79M.
  • Hikari Power's ten largest holdings make up 56% of its $954M portfolio in Q1 2019.
  • Hikari Power opened 5 new positions and closed 5 in Q1 2019.
  • Hikari Power's portfolio value rose 7.4% quarter-over-quarter to $954M.

Based on Hikari Power's 13F filing for Q1 2019, filed 26 Apr 2019.